Can discontinuation of venlafaxine cause hair loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hair Loss from Venlafaxine Discontinuation is Not a Recognized Withdrawal Symptom

Stopping venlafaxine does not cause hair loss. Hair loss is not listed among the documented discontinuation symptoms of venlafaxine, and the evidence suggests that if anything, venlafaxine use itself (not its discontinuation) may be associated with hair loss, though this is rare.

What Actually Happens When You Stop Venlafaxine

Venlafaxine discontinuation is well-characterized and causes a specific withdrawal syndrome. Venlafaxine should be tapered gradually rather than stopped abruptly 1. The FDA drug label clearly documents the discontinuation symptoms that occur with venlafaxine 2:

  • Neurological symptoms: dizziness, sensory disturbances (shock-like electrical sensations), paresthesias, headache, tremor, vertigo
  • Psychiatric symptoms: anxiety, agitation, confusion, irritability, dysphoric mood, insomnia, nightmares, hypomania
  • Gastrointestinal symptoms: nausea, vomiting, diarrhea
  • General symptoms: fatigue, flu-like symptoms, sweating

Notably absent from this comprehensive list: hair loss or alopecia.

Hair Loss and Antidepressants: The Real Story

The relationship between antidepressants and hair loss is the opposite of what your question suggests:

Hair loss occurs during treatment with antidepressants, not after stopping them 3, 4, 5. A large retrospective cohort study of over 1 million patients found that venlafaxine users had a relatively low risk of hair loss compared to bupropion, though higher than some SSRIs 3. When alopecia does occur with antidepressants:

  • It typically develops during active treatment (median onset: 8.6 weeks) 5
  • It affects 12-19% of patients on some mood stabilizers but is much rarer with antidepressants 6
  • Discontinuation of the offending medication leads to hair regrowth in most cases 4, 6

Clinical Implications

If you're experiencing hair loss after stopping venlafaxine, consider alternative explanations:

  • Telogen effluvium from the stress of the underlying psychiatric condition
  • Thyroid dysfunction (which can be comorbid with depression)
  • Nutritional deficiencies
  • Other medications you may be taking
  • Coincidental timing with androgenic alopecia or other hair loss conditions

The 2019 Lancet Psychiatry review of medicines associated with dependence or withdrawal specifically examined antidepressant discontinuation symptoms in detail and did not identify hair loss as a withdrawal symptom 7.

Important Caveat About Discontinuation

While hair loss is not a discontinuation symptom, venlafaxine withdrawal symptoms can be severe and protracted 1, 2. The evidence shows venlafaxine may be associated with greater discontinuation symptoms than other SNRIs 1. A gradual taper over weeks to months is essential to minimize withdrawal effects 2.

References

Guideline

clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, 2020

Research

Alopecia due to psychotropic medications.

The Annals of pharmacotherapy, 1999

Research

Hair loss in psychopharmacology.

Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.